More Stories

Informist, Saturday, Mar. 7, 2026

 

Please click here to read all liners published on this story

--Poly Medicure: Over 100 pdts in development, to be launched in 3-4 yrs 
--Poly Medicure: Plan to double the R&D expenditure in next few years 
--Poly Medicure plans to launch 5-6 new critical care products in FY27 
--Poly Medicure plans to export cardio pdts post clinical trials 
--Poly Medicure plans to export cardio pdts post regulatory approval 
--Poly Medicure: Haryana plant to be completed by FY27 end 

 

MUMBAI – Poly Medicure Ltd. has over 100 products under development and expects to launch them in 3-4 years. In an investor presentation sent to the exchanges, the company said it plans to launch 25-30 products a year over the said period. The company also plans to double its research and development expenditure in the next few years. 

 

The company said registration of Pendracare and Citieffe products are underway in India. Poly Medicure had acquired Italy-based Citieffe and Netherlands-based Pendracare in 2025. The company is also looking for new distributors in northern Europe and expanding its presence in Italy.

 

Poly Medicure plans to tap the export market with its cardio portfolio after clinical trials and regulatory approvals. The company said it recently launched three products and plans to launch 5-6 new products under its critical care segment in the next financial year. The company also plans to expand its current trauma therapy portfolio. Its R&D teams in India and Italy will collaborate to develop and launch ortho plates by 2027-28 (Apr-Mar) with a focus on the US and European markets. Under its pediatrics and neonatology segment, the company plans to launch critical care devices in FY27.

 

In the domestic market, the company said its second plant in Haridwar has started commercial operations and its plant in Haryana will also start operations by end of FY27, increasing capacity of blood bags by 50% and infusion products. Its gamma sterilisation facility has also started operations.

 

Poly Medicure reported a consolidated net profit of INR 709.30 million for the December quarter, on a revenue of INR 4.94 billion. On Friday, shares of company closed 0.3% lower at INR 1,356.10 on the National Stock Exchange. End  

 

Reported by Gopika Balasubramanium

Edited by Ashish Shirke

 

For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.

 

Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.

 

Informist Media Tel +91 (22) 6985-4000

Send comments to feedback@informistmedia.com

 

© Informist Media Pvt. Ltd. 2026. All rights reserved.